drugset / Trial / NCT04914286
A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety/tolerability, pharmacokinetics, and preliminary efficacy of GFH018 in combination with Toripalimab in patients with advanced solid tumors.
Timeline
- Start
- 2021-10-20
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GFH018 | Small molecule | — | Oral |
| Subject | Toripalimab | Monoclonal antibody | 3 mg/kg | Intravenous |
Indications
No indication recorded.